Complementary And Alternative Medicine Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Complementary And Alternative Medicine Market, By Intervention

7.1.  Complementary And Alternative Medicine Market, By Intervention  Type, 2020-2030

7.1.1.    Traditional Alternative Medicine/Botanicals

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Mind Healing

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Body Healing

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    External Energy

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Sensory Healing

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Complementary And Alternative Medicine Market, By Distribution Method

8.1.  Complementary And Alternative Medicine Market, By Distribution Method, 2020-2030

8.1.1.    Direct Sales

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    E-sales

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Distance Correspondence

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Complementary And Alternative Medicine Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Intervention  (2016-2030)

9.1.2.    Market Revenue and Forecast, By Distribution Method (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Intervention  (2016-2030)

9.2.2.    Market Revenue and Forecast, By Distribution Method (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Intervention  (2016-2030)

9.3.2.    Market Revenue and Forecast, By Distribution Method (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Intervention  (2016-2030)

9.4.2.    Market Revenue and Forecast, By Distribution Method (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Intervention  (2016-2030)

9.5.2.    Market Revenue and Forecast, By Distribution Method (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Intervention  (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Distribution Method (2016-2030)

Chapter 10.  Company Profiles

10.1.              Columbia Nutritional

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Nordic Nutraceuticals.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Ramamani Iyengar Memorial Yoga Institute

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              The Healing Company Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              John Schumacher Unity Woods Yoga Centre

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Sheng Chang Pharmaceutical Company

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Pure encapsulations, LLC.

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Herb Pharm

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              AYUSH Ayurvedic Pte Ltd.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms